HAVCR2 and lymphoma: The results of this phenomenon were consistent across a variety of leukemia cell lines and lymphoma cell lines, and targeted blockade of PtdSer or TIM3 reversed the occurrence of immune escape in TMEM30A-deficient tumor cells (26).